| Amgen (AMGN) |
United States |
$108.806B |
12.30 |
| Gilead Sciences (GILD) |
United States |
$85.546B |
10.39 |
| Celgene (CELG) |
United States |
$68.622B |
11.63 |
| Illumina (ILMN) |
United States |
$51.613B |
59.81 |
| Biogen (BIIB) |
United States |
$44.941B |
8.53 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$44.509B |
53.80 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$33.983B |
15.97 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$26.940B |
15.25 |
| Incyte (INCY) |
United States |
$17.550B |
71.17 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$15.072B |
0.00 |
| Exact Sciences (EXAS) |
United States |
$14.452B |
0.00 |
| Seattle Genetics (SGEN) |
United States |
$11.552B |
0.00 |
| Array BioPharma (ARRY) |
United States |
$10.298B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$9.423B |
0.00 |
| QIAGEN (QGEN) |
Netherlands |
$8.939B |
29.36 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$8.674B |
45.98 |
| Bio-Techne Corp (TECH) |
United States |
$7.848B |
53.55 |
| Guardant Health (GH) |
United States |
$7.801B |
0.00 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$7.617B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$6.764B |
0.00 |
| Exelixis (EXEL) |
United States |
$6.235B |
15.89 |
| Amarin (AMRN) |
Ireland |
$6.204B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$6.199B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$5.393B |
0.00 |
| BeiGene (BGNE) |
Cayman Islands |
$5.317B |
0.00 |
| Moderna (MRNA) |
United States |
$5.189B |
0.00 |
| Blueprint Medicines (BPMC) |
United States |
$4.614B |
0.00 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$4.051B |
0.00 |
| Spark Therapeutics (ONCE) |
United States |
$3.829B |
0.00 |
| China Biologic Products (CBPO) |
China |
$3.666B |
23.28 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$3.665B |
0.00 |
| Repligen (RGEN) |
United States |
$3.660B |
91.18 |
| Mirati Therapeutics (MRTX) |
United States |
$3.620B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$3.500B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$3.480B |
0.00 |
| Allogene Therapeutics (ALLO) |
United States |
$3.330B |
0.00 |
| MorphoSys AG Unsponsored ADR (MOR) |
Germany |
$3.113B |
0.00 |
| UniQure (QURE) |
Netherlands |
$3.067B |
0.00 |
| Global Blood Therapeutics (GBT) |
United States |
$3.059B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$2.837B |
5.76 |
| Amicus Therapeutics (FOLD) |
United States |
$2.779B |
0.00 |
| Lion Biotechnologies (IOVA) |
United States |
$2.711B |
0.00 |
| Medicines (MDCO) |
United States |
$2.647B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$2.551B |
0.00 |
| Biohaven Pharmaceutical Holding (BHVN) |
United States |
$2.547B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$2.505B |
0.00 |
| Immunomedics (IMMU) |
United States |
$2.500B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$2.490B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$2.351B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$2.329B |
20.23 |
| NeoGenomics (NEO) |
United States |
$2.301B |
150.63 |
| Akcea Therapeutics (AKCA) |
United States |
$2.263B |
0.00 |
| MyoKardia (MYOK) |
United States |
$2.204B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$2.190B |
18.14 |
| Acceleron Pharma (XLRN) |
United States |
$2.021B |
0.00 |
| Insmed (INSM) |
United States |
$1.965B |
0.00 |
| Genomic Health (GHDX) |
United States |
$1.931B |
41.02 |
| REGENXBIO (RGNX) |
United States |
$1.884B |
0.00 |
| Allakos (ALLK) |
United States |
$1.867B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$1.867B |
0.00 |
| Zai Lab Unsponsored ADR (ZLAB) |
China |
$1.856B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$1.817B |
18.07 |
| AnaptysBio (ANAB) |
United States |
$1.817B |
0.00 |
| Audentes Therapeutics (BOLD) |
United States |
$1.765B |
0.00 |
| Cambrex (CBM) |
United States |
$1.454B |
18.38 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$1.443B |
0.00 |
| Innoviva (INVA) |
United States |
$1.441B |
3.99 |
| Alector (ALEC) |
United States |
$1.402B |
0.00 |
| Gossamer Bio (GOSS) |
United States |
$1.390B |
0.00 |
| Apellis Pharmaceuticals (APLS) |
United States |
$1.382B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.356B |
0.00 |
| Aimmune Therapeutics (AIMT) |
United States |
$1.284B |
0.00 |
| Orchard Therapeutics Sponsored ADR (ORTX) |
United Kingdom |
$1.255B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$1.246B |
0.00 |
| Momenta Pharmaceuticals (MNTA) |
United States |
$1.243B |
0.00 |
| Eidos Therapeutics (EIDX) |
United States |
$1.209B |
0.00 |
| Athenex (ATNX) |
United States |
$1.194B |
0.00 |
| Rubius Therapeutics (RUBY) |
United States |
$1.150B |
0.00 |
| Epizyme (EPZM) |
United States |
$1.128B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.126B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$1.113B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$1.082B |
0.00 |
| Alder BioPharmaceuticals (ALDR) |
United States |
$1.040B |
0.00 |
| CORTEXYME INC (CRTX) |
United States |
$1.026B |
0.00 |
| Atara Biotherapeutics (ATRA) |
United States |
$1.022B |
0.00 |
| Codexis (CDXS) |
United States |
$0.970B |
0.00 |
| RA PHARMCTL INC (RARX) |
United States |
$0.962B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.940B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.928B |
0.00 |
| NGM Biopharmaceuticals (NGM) |
United States |
$0.918B |
0.00 |
| Deciphera Pharmaceuticals (DCPH) |
United States |
$0.881B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.873B |
15.49 |
| Inotek Pharmaceuticals (RCKT) |
United States |
$0.851B |
0.00 |
| Principia Biopharma (PRNB) |
United States |
$0.841B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$0.826B |
0.00 |
| Retrophin (RTRX) |
United States |
$0.822B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.789B |
37.25 |
| Cara Therapeutics (CARA) |
United States |
$0.789B |
0.00 |
| Rhythm Pharmaceuticals (RYTM) |
United States |
$0.786B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$0.780B |
0.00 |
| Axsome Therapeutics (AXSM) |
United States |
$0.772B |
0.00 |
| GENFIT Unsponsored ADR (GNFT) |
France |
$0.771B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.748B |
0.00 |
| Kura Oncology (KURA) |
United States |
$0.744B |
0.00 |
| G1 THERAPEUTICS (GTHX) |
United States |
$0.740B |
0.00 |
| Kiniksa Pharmaceuticals (KNSA) |
Bermuda |
$0.731B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.730B |
0.00 |
| Vericel (VCEL) |
United States |
$0.725B |
0.00 |
| Y-mAbs Therapeutics (YMAB) |
United States |
$0.711B |
0.00 |
| Arvinas (ARVN) |
United States |
$0.709B |
0.00 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.691B |
0.00 |
| Myovant Sciences (MYOV) |
United Kingdom |
$0.677B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$0.671B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$0.662B |
0.00 |
| Stemline Therapeutics (STML) |
United States |
$0.655B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$0.643B |
7.51 |
| Autolus Therapeutics Sponsored ADR (AUTL) |
United Kingdom |
$0.637B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.632B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.627B |
0.00 |
| Cytokineticsorporated (CYTK) |
United States |
$0.621B |
0.00 |
| Heska (HSKA) |
United States |
$0.610B |
62.48 |
| Cellectis (CLLS) |
France |
$0.607B |
0.00 |
| Viking Therapeutics (VKTX) |
United States |
$0.586B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.576B |
19.67 |
| Puma Biotechnology (PBYI) |
United States |
$0.526B |
0.00 |
| Milestone Pharmaceuticals (MIST) |
Canada |
$0.525B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$0.498B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$0.494B |
0.00 |
| DBV Technologies (DBVT) |
France |
$0.492B |
0.00 |
| BeyondSpring (BYSI) |
United States |
$0.489B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.489B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.489B |
0.00 |
| Mesoblast (MESO) |
Australia |
$0.465B |
0.00 |
| Magenta Therapeutics (MGTA) |
United States |
$0.460B |
0.00 |
| ObsEva SA (OBSV) |
Switzerland |
$0.457B |
0.00 |
| ProQR Therapeutics (PRQR) |
Netherlands |
$0.456B |
0.00 |
| Synthorx (THOR) |
United States |
$0.450B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$0.446B |
0.00 |
| Kodiak Sciences (KOD) |
United States |
$0.443B |
0.00 |
| Provention Bio (PRVB) |
United States |
$0.424B |
0.00 |
| Krystal Biotech (KRYS) |
United States |
$0.415B |
0.00 |
| Achillion Pharmaceuticals (ACHN) |
United States |
$0.413B |
0.00 |
| Replimune (REPL) |
United States |
$0.413B |
0.00 |
| Kaleido Biosciences (KLDO) |
|
$0.412B |
0.00 |
| MediciNova (MNOV) |
United States |
$0.410B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$0.403B |
0.00 |
| UNITY Biotechnology (UBX) |
|
$0.393B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.392B |
25.22 |
| Prothena (PRTA) |
Ireland |
$0.388B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.387B |
0.00 |
| Agenus (AGEN) |
United States |
$0.387B |
0.00 |
| Albireo Pharma (ALBO) |
United States |
$0.384B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.383B |
0.00 |
| NuCana Sponsored ADR (NCNA) |
United Kingdom |
$0.378B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.371B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.370B |
6.51 |
| Gritstone Oncology (GRTS) |
United States |
$0.368B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.358B |
8.54 |
| Biofrontera AG Sponsored ADR (BFRA) |
Germany |
$0.358B |
0.00 |
| Senesco Technologies (ELOX) |
United States |
$0.355B |
0.00 |
| Stealth BioTherapeutics Sponsored ADR (MITO) |
United States |
$0.343B |
0.00 |
| ResTORbio (TORC) |
United States |
$0.338B |
0.00 |
| NEXTCURE INC (NXTC) |
United States |
$0.332B |
0.00 |
| AVROBIO (AVRO) |
United States |
$0.326B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.320B |
0.00 |
| LogicBio Therapeutics (LOGC) |
United States |
$0.313B |
0.00 |
| AMAG Pharmaceuticals (AMAG) |
United States |
$0.305B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.302B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.301B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.295B |
0.00 |
| Palatin Technologies (PTN) |
United States |
$0.278B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.277B |
0.00 |
| Cellular Biomedicine (CBMG) |
United States |
$0.274B |
0.00 |
| Geron (GERN) |
United States |
$0.274B |
0.00 |
| Athersys (ATHX) |
United States |
$0.274B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.272B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$0.267B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.264B |
0.00 |
| XBiotech (XBIT) |
United States |
$0.263B |
0.00 |
| Chiasma (CHMA) |
United States |
$0.257B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.255B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$0.253B |
0.00 |
| Constellation Pharmaceuticals (CNST) |
United States |
$0.248B |
0.00 |
| Urovant Sciences (UROV) |
United States |
$0.247B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.241B |
0.00 |
| Evelo Biosciences (EVLO) |
United States |
$0.241B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.240B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.235B |
0.00 |
| BICYCLE THERAPT (BCYC) |
United Kingdom |
$0.234B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.232B |
0.00 |
| MannKind (MNKD) |
United States |
$0.231B |
0.00 |
| Neothetics (EVFM) |
United States |
$0.230B |
0.00 |
| Celcuity (CELC) |
United States |
$0.230B |
0.00 |
| AXCELLA HEALTH (AXLA) |
United States |
$0.229B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.225B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.221B |
8.58 |
| Cerecor (CERC) |
United States |
$0.220B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.220B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$0.220B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.219B |
0.00 |
| Pfenex (PFNX) |
United States |
$0.219B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.214B |
0.00 |
| IDEAYA BIOSCI (IDYA) |
United States |
$0.213B |
0.00 |
| Enochian BioSciences (ENOB) |
United States |
$0.211B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.210B |
0.00 |
| Cel-Sci (CVM) |
United States |
$0.206B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.204B |
0.00 |
| Eiger BioPharmaceuticals (EIGR) |
United States |
$0.202B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.202B |
0.00 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.190B |
0.00 |
| Arsanis (XFOR) |
United States |
$0.183B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.183B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.180B |
10.41 |
| Compugen (CGEN) |
Israel |
$0.178B |
0.00 |
| Solid Biosciences (SLDB) |
United States |
$0.177B |
0.00 |
| HOOKIPA PHARMA (HOOK) |
United States |
$0.177B |
0.00 |
| Gamida Cell (GMDA) |
Israel |
$0.174B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.173B |
0.00 |
| BioXcel Therapeutics (BTAI) |
United States |
$0.171B |
0.00 |
| OvaScience (MLND) |
United States |
$0.170B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.167B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.167B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.165B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.162B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.159B |
0.00 |
| Anavex Life Sciences (AVXL) |
United States |
$0.158B |
0.00 |
| Intec Pharma (NTEC) |
Israel |
$0.158B |
0.00 |
| Kezar Life Sciences (KZR) |
United States |
$0.155B |
0.00 |
| APPLIED THERAPT (APLT) |
United States |
$0.154B |
0.00 |
| BioTime (BTX) |
United States |
$0.154B |
10.30 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.153B |
0.00 |
| Mustang Bio (MBIO) |
United States |
$0.152B |
0.00 |
| Aduro Biotech (ADRO) |
United States |
$0.151B |
0.00 |
| Menlo Therapeutics (MNLO) |
United States |
$0.151B |
0.00 |
| XOMA (XOMA) |
United States |
$0.149B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.143B |
0.00 |
| TOCAGEN INC (TOCA) |
United States |
$0.138B |
0.00 |
| TREVI THERAPTCS (TRVI) |
United States |
$0.137B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.133B |
0.00 |
| Verastem (VSTM) |
United States |
$0.129B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.127B |
0.00 |
| Axovant Sciences (AXGT) |
United States |
$0.126B |
0.00 |
| Erytech Pharma SA Sponsored ADR (ERYP) |
France |
$0.124B |
0.00 |
| VolitionRX (VNRX) |
Singapore |
$0.121B |
0.00 |
| Novavax (NVAX) |
United States |
$0.120B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.117B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.116B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.116B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.115B |
0.00 |
| Aptose Biosciences (APTO) |
Canada |
$0.112B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.112B |
0.00 |
| Corvus Pharmaceuticals (CRVS) |
United States |
$0.106B |
0.00 |
| INmune Bio (INMB) |
United States |
$0.106B |
0.00 |
| Tiziana Life Sciences Sponsored ADR (TLSA) |
United Kingdom |
$0.105B |
0.00 |
| Equillium (EQ) |
United States |
$0.104B |
0.00 |
| Arbutus Biopharma (ABUS) |
Canada |
$0.103B |
0.00 |
| NantKwest (NK) |
United States |
$0.103B |
0.00 |
| Trevena (TRVN) |
United States |
$0.103B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.101B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$0.101B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.099B |
0.00 |
| Allena Pharmaceuticals (ALNA) |
United States |
$0.098B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.090B |
0.00 |
| InflaRx (IFRX) |
Germany |
$0.086B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.085B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.083B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.082B |
0.00 |
| Brainstorm Cell Therapeutics (BCLI) |
United States |
$0.080B |
0.00 |
| Unum Therapeutics (UMRX) |
United States |
$0.078B |
0.00 |
| Merrimack Pharmaceuticals (MACK) |
United States |
$0.075B |
0.00 |
| Cohbar (CWBR) |
United States |
$0.075B |
0.00 |
| Verona Pharma American Depositary Share (VRNA) |
United Kingdom |
$0.073B |
0.00 |
| Signal Genetics (MGEN) |
United States |
$0.073B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.073B |
39.90 |
| VTv Therapeutics (VTVT) |
United States |
$0.072B |
0.00 |
| Spring Bank Pharmaceuticals (SBPH) |
United States |
$0.072B |
0.00 |
| Catabasis Pharmaceuticals (CATB) |
United States |
$0.070B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.070B |
73.33 |
| Orgenesis (ORGS) |
United States |
$0.068B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.066B |
0.00 |
| OVID THERAPEUTC (OVID) |
United States |
$0.065B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.065B |
0.00 |
| Alcobra (ARCT) |
United States |
$0.065B |
0.00 |
| Hoth Therapeutics (HOTH) |
United States |
$0.065B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.065B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.063B |
0.00 |
| ScPharmaceuticals (SCPH) |
United States |
$0.063B |
0.00 |
| Protalix BioTherapeutics (PLX) |
Israel |
$0.063B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.060B |
0.00 |
| Eyenovia (EYEN) |
United States |
$0.059B |
0.00 |
| Aridis Pharmaceuticals (ARDS) |
United States |
$0.058B |
0.00 |
| NewLink Genetics (NLNK) |
United States |
$0.057B |
0.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.057B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.056B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.055B |
0.00 |
| Proteostasis Therapeutics (PTI) |
United States |
$0.053B |
0.00 |
| Moleculin Biotech (MBRX) |
United States |
$0.052B |
0.00 |
| Ophthotech (ISEE) |
United States |
$0.052B |
0.00 |
| Zosano Pharma (ZSAN) |
United States |
$0.050B |
0.00 |
| Curis (CRIS) |
United States |
$0.050B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.049B |
0.00 |
| Apricus Biosciences (SEEL) |
United States |
$0.047B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.046B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.044B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.044B |
0.00 |
| Bellerophon Therapeutics (BLPH) |
United States |
$0.044B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.043B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.043B |
0.00 |
| INNOVATE BIOPHARMACEUTICALS, INC (INNT) |
United States |
$0.040B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.040B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.039B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.039B |
0.00 |
| BiondVax Pharmaceuticals (BVXV) |
Israel |
$0.039B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.038B |
0.00 |
| Celsion (CLSN) |
United States |
$0.037B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$0.036B |
0.00 |
| VIVUS (VVUS) |
United States |
$0.035B |
0.00 |
| Akari Therapeutics (AKTX) |
United Kingdom |
$0.035B |
0.00 |
| Leap Therapeutics (LPTX) |
United States |
$0.035B |
0.00 |
| Oncolytics Biotech (ONCY) |
Canada |
$0.034B |
0.00 |
| AZURRX BIOPHARM (AZRX) |
United States |
$0.033B |
0.00 |
| VistaGen Therapeutics (VTGN) |
United States |
$0.032B |
0.00 |
| Anchiano Therapeutics Sponsored ADR (ANCN) |
Israel |
$0.032B |
0.00 |
| Edge Therapeutics (PDSB) |
United States |
$0.032B |
0.00 |
| Sienna Biopharmaceuticals (SNNA) |
United States |
$0.031B |
0.00 |
| Aytu Bioscience (AYTU) |
United States |
$0.030B |
0.00 |
| Caladrius Biosciences (CLBS) |
United States |
$0.030B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$0.028B |
0.00 |
| Bison Capital Acquisition (XYN) |
China |
$0.025B |
0.00 |
| Histogenics (HSGX) |
United States |
$0.023B |
0.00 |
| Oragenics (OGEN) |
United States |
$0.023B |
0.00 |
| GENPREX INC (GNPX) |
United States |
$0.022B |
0.00 |
| GTx (ONCT) |
United States |
$0.022B |
0.00 |
| Sophiris Bio (SPHS) |
United States |
$0.021B |
0.00 |
| Rexahn Pharmaceuticals (REXN) |
United States |
$0.021B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.020B |
0.00 |
| Adial Pharmaceuticals (ADIL) |
United States |
$0.020B |
0.00 |
| Fibrocell Science Inc (FCSC) |
United States |
$0.019B |
0.00 |
| Vical (VICL) |
United States |
$0.019B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.019B |
0.00 |
| OncoSec Medical (ONCS) |
United States |
$0.018B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.018B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.017B |
0.00 |
| Novelion Therapeutics (NVLN) |
Canada |
$0.016B |
0.00 |
| IBio (IBIO) |
United States |
$0.016B |
0.00 |
| ATyr Pharma (LIFE) |
United States |
$0.016B |
0.00 |
| Gemphire Therapeutics (GEMP) |
United States |
$0.014B |
0.00 |
| Aileron Therapeutics (ALRN) |
United States |
$0.013B |
0.00 |
| TrovaGene (TROV) |
United States |
$0.013B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.013B |
0.00 |
| MYOS RENS Technology (MYOS) |
United States |
$0.013B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.012B |
0.00 |
| Motif Bio Plc (MTFB) |
United States |
$0.012B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.012B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.012B |
0.00 |
| Dare Bioscience (DARE) |
United States |
$0.010B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.010B |
0.00 |
| RestorGenex (DFFN) |
United States |
$0.010B |
0.00 |
| Vital Therapies (IMUX) |
United States |
$0.010B |
0.00 |
| Therapix Biosciences (TRPX) |
Israel |
$0.010B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.010B |
0.00 |
| Hemispherx BioPharma (HEB) |
United States |
$0.009B |
0.00 |
| Flex Pharma (FLKS) |
United States |
$0.009B |
0.00 |
| IMMURON LTD (IMRN) |
Australia |
$0.009B |
0.00 |
| Benitec Biopharma (BNTC) |
Australia |
$0.009B |
0.00 |
| Synthetic Biologics (SYN) |
United States |
$0.009B |
0.00 |
| Tenax Therapeutics (TENX) |
United States |
$0.008B |
0.00 |
| Proteon Therapeutics (PRTO) |
United States |
$0.008B |
0.00 |
| BioPharmX (BPMX) |
United States |
$0.008B |
0.00 |
| Neuralstem (CUR) |
United States |
$0.007B |
0.00 |
| ContraVir Pharmaceuticals Inc (CTRV) |
United States |
$0.007B |
0.00 |
| ARCA Biopharma (ABIO) |
United States |
$0.007B |
0.00 |
| AmpliPhi Biosciences (ARMP) |
United States |
$0.007B |
0.00 |
| Cytori Therapeutics Inc (CYTX) |
United States |
$0.006B |
0.00 |
| Galena Biopharma (SLS) |
United States |
$0.004B |
0.00 |
| Stellar Biotechnologies (EDSA) |
United States |
$0.003B |
0.00 |
| Cellect Biotechnology (APOP) |
Israel |
$0.003B |
0.00 |
| Horizon Pharma Public (HZNP) |
Ireland |
$0.000B |
0.00 |
